CYB5R3c.350C>G与G6PD A等位基因改变疟疾和镰状细胞病贫血严重程度
研究探讨CYB5R3c.350C>G与G6PD A+/A-对疟疾和镰状细胞病贫血的影响。在165例赞比亚疟疾患儿中,无G6PD缺陷者该变异与重症疟疾贫血风险降低相关(OR 0.29,P=0.022),G6PD A+或A-半合子/纯合子中无此关联。在267例儿童和321例成人/青少年SCD患者中,无G6PD缺陷者该变异与更高血红蛋白相关(儿童β=0.29,P=0.022;成人β=0.33,P=0.004)。
要点
- 无G6PD缺陷的疟疾患儿中,CYB5R3c.350C>G与重症疟疾贫血风险降低相关(OR 0.29,P=0.022)。
- G6PD A+或A-半合子/纯合子疟疾患儿中,CYB5R3c.350C>G与重症疟疾贫血无显著关联。
- 无G6PD缺陷的SCD患者中,CYB5R3c.350C>G与更高血红蛋白相关(儿童β=0.29,P=0.022;成人β=0.33,P=0.004)。
核心结论
- CYB5R3c.350C>G似乎可减轻无G6PD缺陷的疟疾和SCD患者的贫血严重程度,可能解释该变异的高患病率。
研究设计与样本
- 研究纳入165例赞比亚疟疾患儿分析CYB5R3c.350C>G与重症贫血(血红蛋白<5 g/dL)的关联,并结合G6PD A+和A-状态。
- 研究纳入美国与英国267例儿童和321例成人/青少年SCD患者,分析CYB5R3c.350C>G与血红蛋白浓度的关系。
- 对SCD红细胞进行功能研究,比较天然CYB5R3T117S与野生型CYB5R3活性及NADH/NAD+比值。
主要发现
- 无G6PD缺陷(G6PD野生型或A+/A-杂合子)的疟疾患儿中,CYB5R3c.350C>G与重症疟疾贫血风险降低相关(OR 0.29,P=0.022)。
- G6PD A+或A-半合子/纯合子的疟疾患儿中,CYB5R3c.350C>G与重症疟疾贫血无显著关联。
- 无G6PD缺陷的SCD儿童中,CYB5R3c.350C>G与更高血红蛋白相关(β=0.29,P=0.022)。
- 无G6PD缺陷的SCD成人/青少年中,CYB5R3c.350C>G与更高血红蛋白相关(β=0.33,P=0.004)。
- SCD红细胞功能研究显示,天然CYB5R3T117S活性较野生型CYB5R3轻度降低,NADH/NAD+比值升高。
关键数值与推荐
- 重症疟疾贫血定义为血红蛋白<5 g/dL。
- CYB5R3c.350C>G在非洲裔美国人中等位基因频率为23%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Genetic modifiers of anemia in Plasmodium falciparum infection and sickle cell disease (SCD) are not fully known. Both conditions are associated with oxidative stress, hemolysis and anemia. The CYB5R3 gene encodes cytochrome b5 reductase 3, which converts methemoglobin to hemoglobin through oxidation of NADH. CYB5R3c.350C > G encoding CYB5R3T117S , the most frequent recognized African-specific polymorphism, does not have known functional significance, but its high allele frequency (23% in African Americans) suggests a selection advantage. Glucose-6-phosphate dehydrogenase (G6PD) is essential for protection from oxidants; its African-polymorphic X-linked A+ and A- alleles, and other variants with reduced activity, coincide with endemic malaria distribution, suggesting protection from lethal infection. We examined the association of CYB5R3c.350C > G with severe anemia (hemoglobin <5 g/dL) in the context of G6PD A+ and A- status among 165 Zambian children with malaria. CYB5R3c.350C > G offered protection against severe malarial anemia in children without G6PD deficiency (G6PD wild type or A+/A- heterozygotes) (odds ratio 0.29, P = .022) but not in G6PD A+ or A- hemizygotes/homozygotes. We also examined the relationship of CYB5R3c.350C > G with hemoglobin concentration among 267 children and 321 adults and adolescents with SCD in the US and UK and found higher hemoglobin in SCD patients without G6PD deficiency (β = 0.29, P = .022 children; β = 0.33, P = .004 adults). Functional studies in SCD erythrocytes revealed mildly lower activity of native CYB5R3T117S compared to wildtype CYB5R3 and higher NADH/NAD+ ratios. In conclusion, CYB5R3c.350C > G appears to ameliorate anemia severity in malaria and SCD patients without G6PD deficiency, possibly accounting for CYB5R3c.350C > G selection and its high prevalence.
引用
- Gordeuk VR, Shah BN, Zhang X, et al. The CYB5R3c .350C>G and G6PD A alleles modify severity of anemia in malaria and sickle cell disease. Am J Hematol. 2020. PMID: 32697331. doi:10.1002/ajh.25941
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。